PATENT CLAIM ANALYSIS

Application Number: 16134070
Application Type: Utility
Filing Date: 2018-09
Publication Date: 2019-03
Patent Classification: ["424", "136100"]

Abstract:
Described herein are methods and compositions relating to methods of inhibiting neutrophils, e.g., inhibiting NET release or NETosis, by means of a DEspR inhibitor, e.g., an anti-DEspR antibody reagent. In some embodiments, the methods can relate to the treatment of a disease, e.g., cancer or a disease wherein neutrophils; NETs; or NETosing or NETting neutrophils contribute to pathogenesis, chronicity, or worsening of disease. In some embodiments, the DEspR inhibitor can be a bi-specific reagent or an antibody-drug conjugate.

Claim (Index 7):
The method of  claim 5 , wherein the anti-DEspR antibody reagent is an anti-DEspR antibody reagent, a monoclonal antibody.

Metadata:
- Claim Count in Document: 20.0
- Percentile: 97.0
- Lexical Diversity: 1.91837
- Patent Class: 424.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['15129956', '15704344', '15441982', '14995679', '14746997']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7509551284644188
- 35 USC 102 Novelty (BERT): 0.51814685577745
- Combined Prediction Score: 0.727674301195722
- Mean Citation Score: 285.856596
- Max Citation Score: 313.76178
- Similarity Product: 234.9940372581232

Labels:
- Claim Label 101: 1
- Claim Label 102: 0
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 0
- Label 101 Adjusted: 1

Dataset: test